Skip to main content
Jane Buckner, MD, Rheumatology, Seattle, WA

Jane Hoyt Buckner MD


Physician

Join to view full profile
  • 1100 9th AveSeattle, WA 98101

  • Phone+1 206-223-6600

Dr. Buckner is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Rheumatology, 1995 - 1999
  • U Washington Affil Hosps
    U Washington Affil Hosps1992 - 1996
  • U Washington Affil Hosps
    U Washington Affil Hosps1992 - 1995
  • U Minnesota
    U Minnesota1991 - 1992
  • Minneapolis VA
    Minneapolis VA1990 - 1991

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1992 - 2027
  • MN State Medical License
    MN State Medical License 1989 - 1993
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014, 2016-2017

Publications & Presentations

PubMed

Journal Articles

  • Autoantibodies Against Neurologic Antigens in Nonneurologic Autoimmunity  
    Jane H Buckner, David A Hafler, Richard J Nowak, The Journal of Immunology
  • Citrullinated Aggrecan Epitopes as Targets of Auto‐Reactive CD4+ T Cells in Patients with Rheumatoid Arthritis  
    Jeffrey Carlin, Jane H Buckner, Eddie A James, Mariana J Kaplan, Arthritis & Rheumatology
  • Research Paper A Novel and Rapid Method to Quantify Treg Mediated Suppression of CD4 T Cells  
    Jane H. Buckner, Carmen Mikacenic, ScienceDirect

Books/Book Chapters

Abstracts/Posters

  • Multiple alterations in IL-2R signaling contribute to decreased response to IL-2 in CD4+ T cells of T1D subjects as revealed by genotype/phenotype analysis.
    Long SA, Cerosaletti K, Shilling H, Zhang S, Zhang Z-Y, Pihoker C, Greenbaum C, Buckner J, Tolerance and Autoimmunity Keystone Symposium, Taos, NM
  • Rapamycin Promotes Induction of CD4+FoxP3+ T cells that Proliferate in Response to Common Gamma Chain Cytokines.
    Long SA, Van Landeghen M., Buckner, JH, Oral presentation, Federation of Clinical Immunology Societies (FOCIS) conference, San Diego, CA
  • Genetic Variation in PTPN22 Corresponds to Altered Signaling in B Lymphocytes.
    Arechiga AF, Buckner JH, American Association of Immunologists meeting, Miami, FL

Lectures

  • Genotype-phenotype analysis reveals common disease mechanisms in autoimmunity. 
    University of California, San Francisco, and Genentech, San Francisco, CA
  • Update on Arthritis Research: Striving for a Cure Together. 
    The Arthritis Foundation, Pacific Northwest Chapter, Shoreline, WA
  • T Cell Immunoregulation. 
    University of Oxford, 14th EASD Oxford Workshop, Oxford, United Kingdom

Other

Press Mentions

  • Benaroya Research Institute — a Global Resource for Disease Researchers
    Benaroya Research Institute — a Global Resource for Disease ResearchersNovember 20th, 2025
  • Age-Related T Cell Changes Weaken Vaccine Response in Older People
    Age-Related T Cell Changes Weaken Vaccine Response in Older PeopleOctober 29th, 2025
  • New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
    New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the MicrobiomeMarch 10th, 2021

Grant Support

  • Microbial Drivers and Pathogenic Mechanisms in Rheumatoid Arthritis Natural HistoryUNIVERSITY OF COLORADO DENVER2026–2031
  • Regulatory T cells maintain immune homeostasis through translation controlBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
  • Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLEBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
  • Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLEBENAROYA RESEARCH INST AT VIRGINIA MASON2023–2028
  • Immune Tolerance NetworkBENAROYA RESEARCH INST AT VIRGINIA MASON2014–2028

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: